Follow
Michael S. Sinha, MD, JD, MPH
Michael S. Sinha, MD, JD, MPH
Verified email at slu.edu - Homepage
Title
Cited by
Cited by
Year
Covid-19—the law and limits of quarantine
WE Parmet, MS Sinha
New England Journal of Medicine 382 (15), e28, 2020
6042020
The Opioid Epidemic: Fixing a Broken Pharmaceutical Market
A Sarpatwari, MS Sinha, AS Kesselheim
Harv. L. & Pol'y Rev. 11, 463, 2017
932017
Regulatory and safety considerations in deploying a locally fabricated, reusable face shield in a hospital responding to the COVID-19 pandemic
A Mostaghimi, MJ Antonini, D Plana, PD Anderson, B Beller, EW Boyer, ...
Med 1 (1), 139-151. e4, 2020
67*2020
Determinants of market exclusivity for prescription drugs in the United States
AS Kesselheim, MS Sinha, J Avorn
JAMA Internal Medicine 177 (11), 1658-1664, 2017
632017
Novel indole chemistry in the synthesis of heterocycles
GW Gribble, MG Saulnier, ET Pelkey, TLS Kishbaugh, Y Liu, J Jiang, ...
Current Organic Chemistry 9 (15), 1493-1519, 2005
602005
Personal Protective Equipment for COVID-19: Distributed Fabrication and Additive Manufacturing
MS Sinha, FT Bourgeois, PK Sorger
American journal of public health 110 (8), 1162-1164, 2020
482020
Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE
AK Cramer, D Plana, H Yang, MM Carmack, E Tian, MS Sinha, ...
Scientific reports 11 (1), 2051, 2021
472021
Fentanyl panic goes viral: the spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media
L Beletsky, S Seymour, S Kang, Z Siegel, MS Sinha, R Marino, A Dave, ...
International Journal of Drug Policy 86, 102951, 2020
402020
Micro‐inequities in Medicine
JK Silver, M Rowe, MS Sinha, DM Molinares, ND Spector, D Mukherjee
PM&R 10 (10), 1106-1114, 2018
352018
Assessing the filtration efficiency and regulatory status of N95s and nontraditional filtering face-piece respirators available during the COVID-19 pandemic
D Plana, E Tian, AK Cramer, H Yang, MM Carmack, MS Sinha, ...
BMC Infectious Diseases 21, 1-13, 2021
34*2021
A panic foretold: Ebola in the United States
WE Parmet, MS Sinha
Critical Public Health 27 (1), 148-155, 2017
312017
The Perils of Panic: Ebola, HIV, and the Intersection of Global Health and Law
MS Sinha, WE Parmet
American Journal of Law & Medicine 42 (2-3), 223-255, 2016
292016
When Markets Fail
JJ Darrow, MS Sinha, AS Kesselheim
Food and Drug Law Journal 73 (3), 361-382, 2018
27*2018
Pharmaceutical Policy in the United States in 2019: An Overview of the Landscape and Avenues for Improvement
AS Kesselheim, MS Sinha, J Avorn, A Sarpatwari
Stan. L. & Pol'y Rev. 30, 421, 2019
252019
FDA and EMA biosimilar approvals
EH Jung, A Sarpatwari, AS Kesselheim, MS Sinha
Journal of general internal medicine 35 (6), 1908-1910, 2020
242020
Social media impact of the Food and Drug Administration's drug safety communication messaging about zolpidem: mixed-methods analysis
MS Sinha, CC Freifeld, JS Brownstein, MM Donneyong, P Rausch, ...
JMIR public health and surveillance 4 (1), e7823, 2018
232018
Regulatory incentives for antibiotic drug development: A review of recent proposals
MS Sinha, AS Kesselheim
Bioorganic & medicinal chemistry 24 (24), 6446-6451, 2016
222016
Assessing legal responses to COVID-19
S Burris, S de Guia, L Gable, D Levin, WE Parmet, N Terry
2020). Assessing Legal Responses to COVID-19. Boston: Public Health Law …, 2020
202020
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012
MS Sinha, M Najafzadeh, EK Rajasingh, J Love, AS Kesselheim
JAMA internal medicine 178 (11), 1458-1466, 2018
202018
A Crisis-Responsive Framework for Medical Device Development Applied to the COVID-19 Pandemic
MJ Antonini, D Plana, S Srinivasan, L Atta, A Achanta, H Yang, ...
Frontiers in digital health 3, 2021
182021
The system can't perform the operation now. Try again later.
Articles 1–20